Objective To evaluate the effectiveness andthe second - line treatment on patients with advanced non - small cell lung cancer ( NSCLC ).

结论多西他赛单药二线治疗晚期 非 小细胞肺癌疗效肯定,耐受性较好.

互联网

Non - small cell lung cancer: about 80 % of lung cancer patients with non - small cell lung cancer.

非 小细胞肺癌: 约80%的肺癌患者有 非 小细胞肺癌.

互联网

The main pathology type is small cell lung cancer ( SCLC ) and non - small cell lung cancer ( NSCLC ).

病理类型以小细胞肺癌和 非 小细胞肺癌为主.

互联网

It is difficult to treat for local advanced and advanced non small cell lung cancer.

局部晚期和晚期非小细胞肺癌一直是治疗上的难点.

互联网

Large cell neuroendocrine lung cancer ( LCNEC ) is the rare subtype of non - small cell lung cancer.

肺大细胞神经内分泌肿瘤是非小细胞肺癌中的一种较罕见的亚型.

互联网